NZH-46182-03134
3 vaccinations
1 coded response
37 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 462 / IN
- Registered
- 2021-04-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-16
Registered in v-safe
-
2021-04-16
Dose 1 — Moderna
- 2021-04-16
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-30
- 2021-05-07
-
2021-05-14
Dose 2 — Moderna
- 2021-05-14
- 2021-05-15
-
2021-05-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-05-17
- 2021-05-18
- 2021-05-19
- 2021-05-20
- 2021-05-23
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-06-18
- 2021-06-25
- 2021-08-13
- 2021-11-12
-
2021-12-21
Dose 3 — Pfizer-BioNTech
- 2021-12-22
- 2021-12-23
- 2021-12-24
- 2021-12-25
- 2021-12-26
- 2021-12-27
- 2021-12-28
-
2022-01-04
Survey response — day 14, dose 3MedDRA: Diarrhoea, Nausea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Diarrhea and nauseousMedDRA releases: 2024-11 · check-in free text available
- 2022-01-11
- 2022-01-18
- 2022-01-27
- 2022-02-03
- 2022-06-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-16 | Moderna | |
| 2 | 2021-05-14 | Moderna | |
| 3 | 2021-12-21 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 3
Symptoms: Diarrhea and nauseous
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release